McLoughlin Margaret has filed 4 insider transactions across 1 company since June 2024.
Most recent transaction: a grant/award of 19547 shares of Quince Therapeutics, Inc. ($QNCX) on January 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Quince Therapeutics, Inc. | $QNCX | McLoughlin Margaret | Not found | A | Director Stock Option (Right to Buy) | 19547 | $0.00 | 19,547.0000 | 55,681,490 | 9999.99% | 0.04% |
| June 4, 2025 | Quince Therapeutics, Inc. | $QNCX | McLoughlin Margaret | Not found | A | Director Stock Option (Right to Buy) | 27000 | $0.00 | 27,000.0000 | 44,001,643 | 9999.99% | 0.06% |
| Jan. 2, 2025 | Quince Therapeutics, Inc. | $QNCX | McLoughlin Margaret | Not found | A | Director Stock Option (right to buy) | 31613 | $0.00 | 31,613.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | Quince Therapeutics, Inc. | $QNCX | McLoughlin Margaret | Not found | A | Employee Stock Option (right to buy) | 27000 | $0.00 | 27,000.0000 | 0 | 9999.99% | 0.00% |